Skip to NavigationSkip to content

News

0
By 2020, 70% of HCPs are expected to be digital natives, whose experiences with mobile, social, and digital technologies in their personal lives...
0
Genmab has secured a new approval for its CD38 monoclonal antibody Darzalex (daratumumab), this time in Japan for the treatment of newly diagnosed...
0
It’s the end of an era at NICE as its Chief Executive Sir Andrew Dillon announces that he will step down from his role at the end of March next...
0
The US Department of Health and Human Services (HHS) has said it will fund the production of MSD’s investigational Ebola vaccine V920 in response...

Features

Ann Costello, Global Franchise Lead, Centralised Solutions at Roche Diagnostics, discusses the increasing need for a personalised approach to...